Arkolith/Insider Trading/LTRN/Form 4

Schalop Lee Troy

DirectorLantern Pharma Inc. (LTRN) · full profile →Form 4 · filed May 14, 2026
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 12, 2026Buy(P)49K$2.06$100K49K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 12, 2026Buy(P)49K—$049K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-023083) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Lantern Pharma Inc.

Build

Ask your agent about LTRN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-26-023083"
Ask your agent
Use Arkolith to summarize insider buying and selling at Lantern Pharma Inc.
over the last 90 days and cite the filings.